Clinical Trial

Impact of RADA16 Use on Outcomes Following Tonsillectomy in Children

Study acronym: RADA16 for Ped
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of the research is to determine if RADA16 (also known as PuraStat®, PuraGel®, or PuraSinus®) improves patient outcomes following pediatric tonsillectomy procedures. Researchers will compare application of device RADA16 to application of no device to see if RADA16 works to treat post tonsillectomy hemorrhage.Participants will: Undergo tonsillectomy procedure. Receive and fill out a survey sent via email every 2 days following their procedure for 15 days, plus an additional survey on day 30, and track their symptoms.
Protocol Amendment History 1 change
critical Recruitment opened 2026-05-23
Trial Details
NCT Number NCT07188779
Lead Sponsor Rutgers, The State University of New Jersey
Conditions Postoperative Pain
Enrollment 134 participants
Start Date 2026-07-09
Primary Completion 2027-12-01 (estimated)
Study Completion 2027-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-07-22